Victim: www.fibrogen.com
Country : US
Actor: ransomhub
Source: http://ransomxifxwc5eteopdobynonjctkxxvap77yqifu2emfbecgbqdw6qd.onion/1af65b8d-f283-4063-849c-4255c9e266ff/
Discovered: 2024-12-03 18:43:38.129778
Published: 2024-12-03 12:36:05.000000
Description : [AI generated] FibroGen, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies to treat serious unmet medical needs. The company focuses on areas such as fibrosis and oncology, with its lead product candidates targeting conditions like chronic kidney disease and anemia. FibroGen harnesses innovative technologies to develop first-in-class therapeutics.
Ransomware Victims – ALL
Other Victims by ransomhub
- Victim: FibroGen, Inc. is a biopharmaceutical company specializing in innovative therapies for serious medical conditions, including fibrosis and oncology.
- Actor: RansomHub is a ransomware group known for targeting various industries, including healthcare and pharmaceuticals, to exploit sensitive data for financial gain.
- Country: The incident occurred in the United States, where the cybersecurity landscape is actively monitored by various agencies, including the Cybersecurity and Infrastructure Security Agency (CISA).
- Cybersecurity Incident: The attack on FibroGen highlights the growing trend of ransomware targeting healthcare organizations, which can jeopardize patient safety and disrupt critical medical services.
- Cyber Agency: The U.S. has established agencies like CISA to provide guidance and support in combating ransomware threats and enhancing national cybersecurity resilience.